© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
April 22nd 2021, 4:00pm
By Steve Rubin
Finding the balance between offering support and guidance while at the same time not overwhelming people going through health scares isn’t easy, writes a cancer survivor. He notes that although it may take some practice to get right, it is an important skill for cancer thrivers to get down.
April 22nd 2021, 3:00pm
By Jamie Cesanek
In this episode of the “CURE® Talks Cancer” podcast, Henry Scowcroft discusses his experiences writing a book about his late wife’s cancer journey and offers advice for other caregivers.
April 22nd 2021, 1:00pm
By Colleen Moretti
Keytruda demonstrated clinical benefit for patients with recurrent and metastatic disease, according to an expert.
April 21st 2021, 9:00pm
By Darlene Dobkowski, MA
Patients with non-small cell lung cancer and a KRAS G12C genetic mutation may benefit from treatment with an inhibitor targeting that mutation, although more research is needed to learn why more patients are not responding to the drug.
April 21st 2021, 6:00pm
Patients with acute myeloid leukemia experience post-traumatic stress disorder symptoms including intrusion, avoidance and hypervigilance one month after diagnosis.
April 21st 2021, 4:00pm
By Eileen Weinmann
A pediatric oncology nurse offers advice for parents or primary caregivers on how to support their child during cancer treatment.
April 21st 2021, 3:00pm
By Erik Ness
In recent years, research in treating small cell lung cancer has broadened, bringing emerging therapies like immunotherapy to the forefront.
April 21st 2021, 1:00pm
By Jessica Skarzynski
Though the two major modalities of surgery and chemotherapy have been constants in pancreatic cancer treatment for many years, patient outcomes have gradually improved over time as doctors have refined their approach, says an expert from the Seattle Cancer Care Alliance.
April 20th 2021, 9:00pm
Certain patients with metastatic renal cell carcinoma may benefit with active surveillance compared with systemic therapy for their management and may also lead to an improved quality of life.
April 20th 2021, 6:00pm
By Meeri Kim
Even with all the recent advances in targeted therapies and immunotherapy drugs, patients with non-small cell lung cancer still need more treatment options. Although it’s early, cell-based therapies have shown some promise, with more research underway.
April 20th 2021, 4:00pm
By Jane Biehl Ph.D.
A cancer survivor describes what “chemo fog” is and writes how many people are now experiencing a double whammy — “pandemic fog.”
April 20th 2021, 3:00pm
After the COVID-19 pandemic caused a delay in cancer screenings, an expert from Karmanos Cancer Hospital and Network urges patients to resume their routine preventative care to avoid any delay in a possible diagnosis.
April 20th 2021, 1:00pm
Active surveillance in sentinel lymph node positive melanoma could delay surgery but may result in the same risk of the cancer coming back.
April 19th 2021, 9:00pm
Median progression-free survival in patients treated with Keytruda was 13.2 months versus 8.3 months with Adcetris, which makes Keytruda an “effective treatment option” for patients in this population who were either ineligible for or relapsed after autologous hematopoietic stem cell transplantation.
April 19th 2021, 6:00pm
By Ryan McDonald
On social media, CURE® recently asked its readers to share if they sought a second opinion when discussing their cancer diagnosis and treatment. Here’s what some of them said.
Upcoming Triage Cancer Conference to Address Financial Toxicity: May 15th
The Pancreatic Standard of Care is No Longer So Standard
Kathy Ireland Joins the National Pediatric Cancer Foundation’s ‘Team 43’ to Raise Funds and Awareness